P53 binding T cell receptor molecules
View Patent ↗The invention provides T-cell receptor (TCR) molecules comprising a Vα chain and a Vβ chain that bind peptides derived from the p53 protein, preferably, the human p53 protein. The TCR molecules include both heterodimeric molecules and single chain molecules which specifically bind a sequence preferably spanning about amino acid positions 264-272 of the p53 protein displayed in the context of an HLA molecule, preferably, HLA-A2.1. Also disclosed are methods for making and using such TCR molecules. The invention has a wide spectrum of useful application including therapeutic uses and use in the detection of cells expressing p53 protein.
1. An isolated T cell receptor (TCR) comprising a Vα3 chain as set forth as residues 1-113 of SEQ ID NO. 2 and a Vβ3 chain as set forth as residues 138-251 of SEQ ID NO. 2, wherein the TCR is capable of binding a p53 peptide comprising the sequence set forth as Leu Leu Gly Arg Asn Ser Phe Glu Val (SEQ ID NO. 1) in the context of an MHC molecule, wherein the MHC molecule comprises an HLA A2 molecule.
2. The isolated TCR of claim 1 , wherein the Vα-chain comprises covalently linked in sequence: a) a Vα chain and b) a Cα chain.
3. The isolated TCR of claim 1 , wherein the Vβ-chain comprises covalently linked in sequence: a Vβ chain, and a Cβ sequence.
4. The isolated TCR of claim 1 , wherein binding is determined by monitoring binding of the TCR to an MHC molecule complexed with a peptide comprising the amino acid sequence according to SEQ ID NO:1, wherein the MHC molecule comprises an HLA A2 molecule.
5. The isolated TCR of claim 4 , wherein the binding is monitored in a TCR ELISA or a standard TCR binding assay.
6. The isolated TCR of claim 4 , wherein binding is monitored by measuring signal transduction by the TCR.
7. The isolated TCR of claim 4 , wherein binding between the amino acid sequence and the TCR molecule is increased by at least about 2 fold when compared to a control TCR heterodimer.
8. The isolated TCR of claim 1 , further comprising a Cβ sequence as set forth as residues 252-377 of SEQ ID NO:2.
9. The isolated TCR of claim 1 , further comprising a Cα sequence as set forth as SEQ ID NO:3.
10. The isolated TCR of claim 1 , wherein said TCR comprises a heterodimer.
11. The isolated TCR of claim 1 , wherein said TCR comprises a single chain TCR (scTCR).
12. The isolated single chain TCR (scTCR) of claim 11 , wherein the Vα3 chain is covalently linked to a Vβ3 chain by a peptide linker sequence.
13. The scTCR of claim 11 , wherein the scTCR comprises a transmembrane domain.
14. The scTCR of claim 11 , wherein the scTCR comprises a CD zeta cytoplasmic signaling domain.
15. A single chain T-cell receptor (scTCR), wherein the scTCR comprises in sequence a) a Vα3 chain as set forth as amino acid residues 1-113 of SEQ ID NO:2, b) a peptide linker, and c) a Vβ3 chain as set forth as amino acid residues 138-251 of SEQ ID NO. 2.
16. The scTCR of claim 15 further comprising a Cβ chain as set forth as amino acid residues 252-377 of SEQ ID NO. 2 linked to the C-terminus of the Vβ3 chain.
17. The scTCR of any of claims 15 - 16 , further comprising a fragment of the Cα chain as provided in FIG. 5 (SEQ ID NO: 3), the fragment being covalently linked between the C-terminus of the Vα chain and the N-terminus of the peptide linker.
18. The scTCR of claim 15 , wherein the peptide linker has the following sequence: Gly Gly Gly Gly Ser (SEQ ID NO: 5) repeated at least four times.
19. An isolated T cell receptor comprising SEQ ID NO:2.
20. The isolated T cell receptor of claim 19 , further comprising the Cα chain as set forth as SEQ ID NO:3.
21. An isolated T cell receptor consisting of SEQ ID NO:2, 3, and 5.
22. The scTCR of claim 15 , wherein the Vα3 chain consists of the amino acid sequence as set forth as residues 1-113 of SEQ ID NO: 2 and the Vβ3 chain consists of the amino acid sequence as set forth as residues 138-251 of SEQ ID NO: 2.
23. The TCR of claim 1 , wherein the Vα3 chain consists of the amino acid sequence as set forth as residues 1-113 of SEQ ID NO:2 and wherein the Vβ3 chain consists of the amino acid sequence as set forth as residues 138-251 of SEQ ID NO: 2.